{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:29:59Z","timestamp":1778221799825,"version":"3.51.4"},"reference-count":49,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2022,4,3]]},"DOI":"10.1080\/17474086.2022.2061947","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T15:51:25Z","timestamp":1649346685000},"page":"285-293","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["An evaluation of pembrolizumab for classical Hodgkin lymphoma"],"prefix":"10.1080","volume":"15","author":[{"given":"Farheen","family":"Manji","sequence":"first","affiliation":[{"name":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob C","family":"Laister","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kuruvilla","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510093"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.798868"},{"issue":"2","key":"cit0003","first-page":"467","volume":"20","author":"Ferm\u00e9 C","year":"2002","journal-title":"J clin oncol"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.26.021607.090331"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282780"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.05.002"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.4482"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2004.07.083"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112741"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00319-13"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132706"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00767.x"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-843714"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.3994"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.3129"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2016.77"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2015.09.010"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2017.06.011"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.448126"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712278105"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3467"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.1316"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30406-5"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001367"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000324"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1602262"},{"key":"cit0027","unstructured":"Keytruda: Highlights of Prescribing Information [Internet]. 2020. [cited 2021 Feb 21]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/125514s066lbl.pdf"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30167-X"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087"},{"key":"cit0030","unstructured":"Opdivo: highlights of Prescribing Information. 2019. 2021 Feb 21]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/125554s070lbl.pdf"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139416"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.8005"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00005-X"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2018.09.015"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501824"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2019.02.018"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1159\/000503566"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1320"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60165-9"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000215"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761346"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-738385"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-02-811174"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007400"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01056"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-6367(21)00097-X"},{"key":"cit0047","volume-title":"Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed\/Refractory Classical Hodgkin Lymphoma: no Impairment in Stem Cell Mobilization or Engraftment","author":"Bryan LJ","year":"2019"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-118198"},{"issue":"21","key":"cit0049","first-page":"2401","volume":"136","author":"Bartlett NL","year":"2020","journal-title":"Blood J Am Soc Hematol"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2022.2061947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T14:02:01Z","timestamp":1652450521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2022.2061947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,3]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,3]]}},"alternative-id":["10.1080\/17474086.2022.2061947"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2022.2061947","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-05-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}